AB Science: initiation of a new phase 3 study in oncology with masitinib in patients with metastatic colorectal cancer
December 02, 2013 12:00 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 2 December 2013, 6:00 pm AB Science...
AB Science: 2014 Financial Calendar
November 29, 2013 14:00 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 29 November 2013, 8:00 pm FINANCIAL...
AB Science : Calendrier financier 2014
November 29, 2013 14:00 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 29 novembre 2013, 20h00 CALENDRIER...
AB Science: AB Science announces that CHMP has adopted a first negative opinion for Masitinib in second-line treatment of Gastro-Intestinal Stromal Tumor (GIST)
November 21, 2013 14:31 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 21 November 2013, 8:00 pm AB Science...
AB Science : AB Science annonce que le CHMP a émis une première opinion négative pour le masitinib dans le traitement de deuxième ligne des tumeurs stromales gastro-intestinales (GIST)
November 21, 2013 14:31 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 21 Novembre 2013, 20h00 AB Science...
AB Science: Final results of phase 3 mastocytosis study expected by end of 2014
November 12, 2013 12:22 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 12 November 2013, 6:15 pm Final...
AB Science : Résultats définitifs de l'étude de phase 3 de la mastocytose attendus fin 2014
November 12, 2013 12:22 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 12 Novembre 2013, 18h15 Résultats...
AB Science : Le masitinib passe avec succès l'analyse de futilité dans l'étude clinique pivot de la mastocytose
November 11, 2013 11:45 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 11 Novembre 2013, 17h45 Le masitinib passe...
AB Science: Masitinib successfully passes futility analysis in pivotal clinical study in Mastocytosis
November 11, 2013 11:45 ET
|
AB Science
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Paris, 11 November 2013, 5:45 pm Masitinib...
Acceleration of Clinical Program in Amyotrophic Lateral Sclerosis (ALS) Confirms the Proof of Efficacy Data Obtained in Animals
November 06, 2013 13:26 ET
|
AB Science
PARIS, Nov. 6, 2013 (GLOBE NEWSWIRE) -- AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors...